Advertisement

HindustanTimes Thu,02 Oct 2014

Sun Pharma acquires US-based Pharmalucence

PTI  New Delhi, July 16, 2014
First Published: 11:11 IST(16/7/2014) | Last Updated: 13:26 IST(16/7/2014)

Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.

Advertisement

Pharmalucence, which has sterile injectable capacity in the US, has been acquired by one of the subsidiaries of Sun Pharma, the Mumbai-based firm said in a statement on Wednesday.

The company, however, did not disclose the financial details of the deal.

Earlier this year, Sun Pharma had acquired Ranbaxy Laboratories in an all-stock transaction with a total equity value of USD 3.2 billion along with debt of USD 800 million, taking the overall deal value to USD 4 billion.

Sun Pharma shares were trading at Rs. 748.30, up 1.30% from its previous close.


Advertisement
more from Business

Vijay Mallya has to clear loan defaults to serve as USL chairman: Diageo

Loan default cases against Vijay Mallya and his UB Group may cast a shadow over his continuation as chairman of United Spirits Ltd in the future, with its current parent, UK-based Diageo, making it clear in a statement from its headquarters in London.

markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved